Seladelpar in Subjects With Primary Biliary Cholangitis (PBC) and Compensated Cirrhosis

Clinical trial NCT06051617 · RECRUITING

Trial details

NCT number: NCT06051617
Sponsor: Gilead Sciences
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Primary Biliary Cholangitis

Start date: 2023-09-07
Primary completion: 2030-08-01
Enrollment: 318

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.